Hypertension Trial, Recruiting NCT04783597 Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT04783597
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are pregnant with one baby (not twins or more)
  • People who have at least one high-risk factor, or at least two moderate-risk factors, for developing pre-eclampsia (a serious condition that can occur during pregnancy — the trial site can clarify which factors apply)

Who may not be able to join:

  • People who are more than 14 weeks pregnant at the time of joining
  • People who are pregnant with more than one baby (such as twins or triplets)
  • People with a history of heart disease, stroke, or problems with blood flow in the arteries of the legs or arms
  • People who have certain infectious diseases or conditions, including Hepatitis B, Hepatitis C, HIV, or COVID-19

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Stella S Daskalopoulou, MD, PhD, Research Institute of the McGill University Health Centre

Phone: 514 934-1934

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Registry
ClinicalTrials.gov
Start date
12 July 2021
Est. completion
1 January 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Diagnosis of pre-eclampsia

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov